Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer

Kwang Hyuck Lee, Craig Lotterman, Collins Karikari, Noriyuki Omura, Georg Feldmann, Nils Habbe, Michael G. Goggins, Joshua T. Mendell, Anirban Maitra

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

Aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the putative mechanisms regulating miRNAs per se are only partially known. It is well established that many tumor suppressor genes in human cancers are silenced by chromatin alterations, including promoter methylation and histone deacetylation. We postulated that miRNAs undergo similar epigenetic inactivation in pancreatic cancer. Two human pancreatic cancer cell lines - MiaPACA-2 and PANC-1 - were treated with the demethylating agent, 5-aza-2′-deoxycytidine (5-Aza-dC) or the histone deacetylase inhibitor, trichostatin A, as well as the combination of the two. Expression of miRNAs in control and treated cell lines was assessed using a custom microarray platform. Fourteen miRNAs were upregulated two-fold or greater in each of the cell lines following exposure to both chromatin-modifying agents, including 5 that were in common (miR-107, miR-103, miR-29a, miR-29b, and miR-320) to both MiaPACA-2 and PANC-1. The differential overexpression of miR-107 in the treated cancer cell lines was confirmed by Northern blot assays. Methylation-specific PCR assays for assessment of CpG island methylation status in the 5′ promoter region of the miR-107 primary transcript demonstrated complete loss of methylation upon exposure to 5-Aza-dC. Enforced expression of miR-107 in MiaPACA-2 and PANC-1 cells downregulated in vitro growth, and this was associated with repression of the putative miR-107 target, cyclin-dependent kinase 6, thereby providing a functional basis for the epigenetic inactivation of this miRNA in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)293-301
Number of pages9
JournalPancreatology
Volume9
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Cyclin-Dependent Kinase 6
MicroRNAs
Pancreatic Neoplasms
Epigenomics
decitabine
Methylation
Cell Line
Chromatin
trichostatin A
Neoplasms
CpG Islands
Histone Deacetylase Inhibitors
Tumor Suppressor Genes
Genetic Promoter Regions
Northern Blotting
Histones
Down-Regulation
Polymerase Chain Reaction
Growth

Keywords

  • MicroRNA
  • MiR-107
  • Promoter methylation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Lee, K. H., Lotterman, C., Karikari, C., Omura, N., Feldmann, G., Habbe, N., ... Maitra, A. (2009). Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology, 9(3), 293-301. https://doi.org/10.1159/000186051

Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. / Lee, Kwang Hyuck; Lotterman, Craig; Karikari, Collins; Omura, Noriyuki; Feldmann, Georg; Habbe, Nils; Goggins, Michael G.; Mendell, Joshua T.; Maitra, Anirban.

In: Pancreatology, Vol. 9, No. 3, 05.2009, p. 293-301.

Research output: Contribution to journalArticle

Lee, KH, Lotterman, C, Karikari, C, Omura, N, Feldmann, G, Habbe, N, Goggins, MG, Mendell, JT & Maitra, A 2009, 'Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer', Pancreatology, vol. 9, no. 3, pp. 293-301. https://doi.org/10.1159/000186051
Lee, Kwang Hyuck ; Lotterman, Craig ; Karikari, Collins ; Omura, Noriyuki ; Feldmann, Georg ; Habbe, Nils ; Goggins, Michael G. ; Mendell, Joshua T. ; Maitra, Anirban. / Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. In: Pancreatology. 2009 ; Vol. 9, No. 3. pp. 293-301.
@article{e19a3235ba76405fa2d004ba96c15a3d,
title = "Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer",
abstract = "Aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the putative mechanisms regulating miRNAs per se are only partially known. It is well established that many tumor suppressor genes in human cancers are silenced by chromatin alterations, including promoter methylation and histone deacetylation. We postulated that miRNAs undergo similar epigenetic inactivation in pancreatic cancer. Two human pancreatic cancer cell lines - MiaPACA-2 and PANC-1 - were treated with the demethylating agent, 5-aza-2′-deoxycytidine (5-Aza-dC) or the histone deacetylase inhibitor, trichostatin A, as well as the combination of the two. Expression of miRNAs in control and treated cell lines was assessed using a custom microarray platform. Fourteen miRNAs were upregulated two-fold or greater in each of the cell lines following exposure to both chromatin-modifying agents, including 5 that were in common (miR-107, miR-103, miR-29a, miR-29b, and miR-320) to both MiaPACA-2 and PANC-1. The differential overexpression of miR-107 in the treated cancer cell lines was confirmed by Northern blot assays. Methylation-specific PCR assays for assessment of CpG island methylation status in the 5′ promoter region of the miR-107 primary transcript demonstrated complete loss of methylation upon exposure to 5-Aza-dC. Enforced expression of miR-107 in MiaPACA-2 and PANC-1 cells downregulated in vitro growth, and this was associated with repression of the putative miR-107 target, cyclin-dependent kinase 6, thereby providing a functional basis for the epigenetic inactivation of this miRNA in pancreatic cancer.",
keywords = "MicroRNA, MiR-107, Promoter methylation",
author = "Lee, {Kwang Hyuck} and Craig Lotterman and Collins Karikari and Noriyuki Omura and Georg Feldmann and Nils Habbe and Goggins, {Michael G.} and Mendell, {Joshua T.} and Anirban Maitra",
year = "2009",
month = "5",
doi = "10.1159/000186051",
language = "English (US)",
volume = "9",
pages = "293--301",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer

AU - Lee, Kwang Hyuck

AU - Lotterman, Craig

AU - Karikari, Collins

AU - Omura, Noriyuki

AU - Feldmann, Georg

AU - Habbe, Nils

AU - Goggins, Michael G.

AU - Mendell, Joshua T.

AU - Maitra, Anirban

PY - 2009/5

Y1 - 2009/5

N2 - Aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the putative mechanisms regulating miRNAs per se are only partially known. It is well established that many tumor suppressor genes in human cancers are silenced by chromatin alterations, including promoter methylation and histone deacetylation. We postulated that miRNAs undergo similar epigenetic inactivation in pancreatic cancer. Two human pancreatic cancer cell lines - MiaPACA-2 and PANC-1 - were treated with the demethylating agent, 5-aza-2′-deoxycytidine (5-Aza-dC) or the histone deacetylase inhibitor, trichostatin A, as well as the combination of the two. Expression of miRNAs in control and treated cell lines was assessed using a custom microarray platform. Fourteen miRNAs were upregulated two-fold or greater in each of the cell lines following exposure to both chromatin-modifying agents, including 5 that were in common (miR-107, miR-103, miR-29a, miR-29b, and miR-320) to both MiaPACA-2 and PANC-1. The differential overexpression of miR-107 in the treated cancer cell lines was confirmed by Northern blot assays. Methylation-specific PCR assays for assessment of CpG island methylation status in the 5′ promoter region of the miR-107 primary transcript demonstrated complete loss of methylation upon exposure to 5-Aza-dC. Enforced expression of miR-107 in MiaPACA-2 and PANC-1 cells downregulated in vitro growth, and this was associated with repression of the putative miR-107 target, cyclin-dependent kinase 6, thereby providing a functional basis for the epigenetic inactivation of this miRNA in pancreatic cancer.

AB - Aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the putative mechanisms regulating miRNAs per se are only partially known. It is well established that many tumor suppressor genes in human cancers are silenced by chromatin alterations, including promoter methylation and histone deacetylation. We postulated that miRNAs undergo similar epigenetic inactivation in pancreatic cancer. Two human pancreatic cancer cell lines - MiaPACA-2 and PANC-1 - were treated with the demethylating agent, 5-aza-2′-deoxycytidine (5-Aza-dC) or the histone deacetylase inhibitor, trichostatin A, as well as the combination of the two. Expression of miRNAs in control and treated cell lines was assessed using a custom microarray platform. Fourteen miRNAs were upregulated two-fold or greater in each of the cell lines following exposure to both chromatin-modifying agents, including 5 that were in common (miR-107, miR-103, miR-29a, miR-29b, and miR-320) to both MiaPACA-2 and PANC-1. The differential overexpression of miR-107 in the treated cancer cell lines was confirmed by Northern blot assays. Methylation-specific PCR assays for assessment of CpG island methylation status in the 5′ promoter region of the miR-107 primary transcript demonstrated complete loss of methylation upon exposure to 5-Aza-dC. Enforced expression of miR-107 in MiaPACA-2 and PANC-1 cells downregulated in vitro growth, and this was associated with repression of the putative miR-107 target, cyclin-dependent kinase 6, thereby providing a functional basis for the epigenetic inactivation of this miRNA in pancreatic cancer.

KW - MicroRNA

KW - MiR-107

KW - Promoter methylation

UR - http://www.scopus.com/inward/record.url?scp=65449166892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449166892&partnerID=8YFLogxK

U2 - 10.1159/000186051

DO - 10.1159/000186051

M3 - Article

VL - 9

SP - 293

EP - 301

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 3

ER -